[ORGANIZATION]
Vyjuvek
Featured in 6 tracked stories · first seen
Situations
AIFA rare disease treatment approvals in Italy
2 clusters · 24 sources · last updated
Latest: Italy approves reimbursement for mirdametinib to treat neurofibromatosis type 1
The Italian Medicines Agency (AIFA) has expanded the reimbursement of several specialized therapies through the National Health Service. On October 29, 2026, AIFA approved reimbursement for beremagene geperpavec (Vyjuv
Epidermolysis bullosa care and treatment developments
2 clusters · 4 sources · last updated
Latest: Medical advancements and specialized care for epidermolysis bullosa patients
Patients with epidermolysis bullosa (EB), a rare genetic condition characterized by extreme skin fragility, are experiencing both diagnostic challenges and advancements in specialized care across several regions. In Col
Also covered in
-
Croatia: Petition gathers 40,000 signatures for rare skin disease treatment
[HEALTH] · 2 sources ·
-
Canary Health Service begins treatment for Butterfly Skin patients
[HEALTH] · 2 sources ·